Based on their extensive experience advising health care industry clients, Epstein Becker Green attorneys and strategic advisors from EBG Advisors are predicting the “hot” health care sectors for investment, growth, and...more
1/9/2020
/ Artificial Intelligence ,
Biologics ,
Clinical Trials ,
Electronic Medical Records ,
Health Care Providers ,
Health Information Technologies ,
Health Insurance ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Long Term Care Facilities ,
Medical Devices ,
Medicare Advantage ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Private Equity ,
Research and Development ,
Telehealth ,
Telemedicine
On September 1, 2015, the Centers for Medicare & Medicaid Services (“CMS”) announced[1] the opportunity for plan sponsors to test value-based insurance design (“VBID”) in the Medicare Advantage (“MA”) market. VBID refers to...more
On February 12, 2015, the Centers for Medicare & Medicaid Services (“CMS”) released an updated version of its Medicare Advantage (“MA”) and prescription drug benefit (“Part D”) plan audit protocols and also announced the...more
Medicare Advantage (“MA”) plans, prescription drug plans (“PDPs”), and other stakeholders have until November 3, 2014, to provide input into the Centers for Medicare & Medicaid Services’ (“CMS’s”) consideration of potential...more